9th Circuit Won’t Rehear Pharma Co.’s Preempted UCL Claim Over ‘Copy’ Of Drug
SAN FRANCISCO — The Ninth Circuit U.S. Court of Appeals denied a pharmaceutical company’s petition for rehearing en banc of the panel’s affirmance on preemption grounds of the dismissal of its...To view the full article, register now.
Already a subscriber? Click here to view full article